Key result
The prevalence of diabetes in COPD varies between 2% and 37%, with patients exhibiting asthma overlap or obese phenotypes being at particular risk for type 2 diabetes.
Why the study?
Although diabetes is an important comorbidity in COPD, the exact links, prevalence, risk factors, and interactions between these two conditions remain controversial.
Design
Review
Authors
Loading...
Supports considering diabetes screening in obese or asthma-overlap COPD phenotypes; leaves open standardized prevalence and causal management implications.
This review highlights the complex relationship and varying prevalence (2-37%) of diabetes in COPD patients, emphasizing the role of specific phenotypes and traditional risk factors.
Covanţev et al. (2022) conducted a review in COPD and Diabetes Mellitus. COPD was evaluated on Prevalence, risk factors, and interactions between COPD and diabetes mellitus. The prevalence of diabetes in COPD varies between 2% and 37%, with patients exhibiting asthma overlap or obese phenotypes being at particular risk for type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: